- Home
- ARTW vs SCNX Comparison
ARTW vs SCNX Comparison
Compare ARTW & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARTW | SCNX |
|---|---|---|
| Founded | 1956 | 2010 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Industrial Machinery/Components | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 16.2M |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ARTW | SCNX |
|---|---|---|
| Price | $3.08 | $2.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.5K | ★ 53.8K |
| Earning Date | 10-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 233.33 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $22,975,408.00 | $3,831,778.00 |
| Revenue This Year | N/A | $1,009.57 |
| Revenue Next Year | N/A | $259.51 |
| P/E Ratio | $74.78 | ★ N/A |
| Revenue Growth | N/A | ★ 30.72 |
| 52 Week Low | $2.05 | $2.81 |
| 52 Week High | $4.17 | $106.25 |
Technical Indicators
Market Signals| Indicator | ARTW | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 46.92 |
| Support Level | $2.95 | N/A |
| Resistance Level | $3.03 | $11.68 |
| Average True Range (ATR) | 0.24 | 8.43 |
| MACD | -0.04 | -1.26 |
| Stochastic Oscillator | 2.67 | 0.09 |
Price Performance
Historical ComparisonAbout ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.